Avantor, Inc. engages in the provision of mission-critical products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides logistics, chemical and equipment tracking, and glassware autoclaving, as well as scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Stock data | 2023 | Change |
---|---|---|
Price | $25.58 | N/A |
Market Cap | $17.30B | N/A |
Shares Outstanding | 676.39M | 3.92% |
Employees | 14.50K | N/A |
Valuation | 2023 | Change |
---|---|---|
P/S Ratio | 2.48 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $6.97B | N/A |
Earnings | $321.10M | N/A |
Gross Margin | 0.3393 | N/A |
Operating Margin | 0.123 | N/A |
Net income margin | 0.0461 | N/A |